Literature DB >> 3663957

Meningeal carcinomatosis from breast cancer: spinal cord vs. brain involvement.

G Clamon1, B Doebbeling.   

Abstract

Twenty-two patients with meningeal carcinoma due to breast cancer were retrospectively evaluated to determine what prognostic factors affected survival. Five patients survived for more than one year. The therapy in these long-term survivors was similar to that of those suffering early death. Patients with primarily brain symptoms survived a median of 21 days vs. 150 days in those with primarily spinal cord symptoms (p = 0.026). The site of involvement may be an important stratification parameter for future prospective trials.

Entities:  

Mesh:

Year:  1987        PMID: 3663957     DOI: 10.1007/bf01806382

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  13 in total

1.  Meningeal carcinomatosis. Case report and review of the literature.

Authors:  D Bramlet; J Giliberti; J Bender
Journal:  Neurology       Date:  1976-03       Impact factor: 9.910

2.  Infiltration of the leptomeninges by systemic cancer. A clinical and pathologic study.

Authors:  M E Olson; N L Chernik; J B Posner
Journal:  Arch Neurol       Date:  1974-02

3.  Meningeal carcinomatosis. Clinical manifestations.

Authors:  J R Little; A J Dale; H Okazaki
Journal:  Arch Neurol       Date:  1974-02

Review 4.  Cerebrospinal fluid biochemical markers in central nervous system tumors: a review.

Authors:  W R Wasserstrom; M K Schwartz; M Fleisher; J B Posner
Journal:  Ann Clin Lab Sci       Date:  1981 May-Jun       Impact factor: 1.256

5.  Intracranial metastases from systemic cancer.

Authors:  J B Posner; N L Chernik
Journal:  Adv Neurol       Date:  1978

6.  Treatment for meningeal carcinomatosis in breast cancer.

Authors:  H Y Yap; B S Yap; S Rasmussen; M E Levens; G N Hortobagyi; G R Blumenschein
Journal:  Cancer       Date:  1982-07-15       Impact factor: 6.860

7.  Comparing survival of responders and nonresponders after treatment: a potential source of confusion in interpreting cancer clinical trials.

Authors:  G B Weiss; H Bunce; J A Hokanson
Journal:  Control Clin Trials       Date:  1983-03

8.  Meningeal carcinomatosis in patients with primary breast or lung cancer.

Authors:  S C Sorensen; R T Eagan; M Scott
Journal:  Mayo Clin Proc       Date:  1984-02       Impact factor: 7.616

9.  Neoplastic meningitis. Marked variations of cerebrospinal fluid composition in the absence of extradural block.

Authors:  J J Murray; F A Greco; S N Wolff; J D Hainsworth
Journal:  Am J Med       Date:  1983-08       Impact factor: 4.965

10.  Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients.

Authors:  W R Wasserstrom; J P Glass; J B Posner
Journal:  Cancer       Date:  1982-02-15       Impact factor: 6.860

View more
  6 in total

1.  Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD).

Authors:  Sherise D Ferguson; Shivani Bindal; Roland L Bassett; Lauren E Haydu; Ian E McCutcheon; Amy B Heimberger; Jing Li; Barbara J O'Brien; Nandita Guha-Thakurta; Michael T Tetzlaff; Hussein Tawbi; Michael A Davies; Isabella C Glitza
Journal:  J Neurooncol       Date:  2019-03-07       Impact factor: 4.130

2.  Outcome after whole brain radiotherapy alone in intracranial leptomeningeal carcinomatosis from solid tumors.

Authors:  C Gani; A C Müller; F Eckert; C Schroeder; B Bender; G Pantazis; M Bamberg; B Berger
Journal:  Strahlenther Onkol       Date:  2012-01-11       Impact factor: 3.621

3.  Prognostic factors and outcomes in patients with leptomeningeal melanomatosis.

Authors:  Laura Harstad; Kenneth R Hess; Morris D Groves
Journal:  Neuro Oncol       Date:  2008-08-14       Impact factor: 12.300

4.  A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies.

Authors:  Morris D Groves; Michael J Glantz; Marc C Chamberlain; Karen E Baumgartner; Charles A Conrad; Sigmund Hsu; Jeffrey S Wefel; Mark R Gilbert; Sandra Ictech; Kathy U Hunter; Arthur D Forman; Vinay K Puduvalli; Howard Colman; Kenneth R Hess; W K Alfred Yung
Journal:  Neuro Oncol       Date:  2008-03-03       Impact factor: 12.300

5.  Retrospective Analysis of Cerebrospinal Fluid Profiles in 228 Patients with Leptomeningeal Carcinomatosis : Differences According to the Sampling Site, Symptoms, and Systemic Factors.

Authors:  Youngbo Shim; Ho-Shin Gwak; Sohee Kim; Jungnam Joo; Sang-Hoon Shin; Heon Yoo
Journal:  J Korean Neurosurg Soc       Date:  2016-10-24

6.  Carcinomatous meningitis: Leptomeningeal metastases in solid tumors.

Authors:  Emilie Le Rhun; Sophie Taillibert; Marc C Chamberlain
Journal:  Surg Neurol Int       Date:  2013-05-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.